This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Drummond Rennie, MD

JAMA. 1997;277(15):1238-1243.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In this issue of THE JOURNAL, we are publishing a report¹ of work that started 9 years ago, was concluded in December 1990, and the data from which were published in another journal in July 1995. Given that we at JAMA like to keep up-to-date and that we try never to republish what others have already put in print, the reader might well ask what is going on. The story necessary to answer this question provides a cautionary tale that illustrates the sharply differing views of research taken by the university researcher and the company sponsoring that research, if the company's product is at stake. At a time when an increasing proportion of research funding is provided by private companies,² the story holds lessons for both, as well as for university faculties, administrators, regulatory agencies, and for physicians who prescribe on the basis of evidence.

See also pp . . . [Full Text PDF of this Article]

Author Affiliations
From the Institute of Health Policy Research, University of California, San Francisco. Dr Rennie is also Deputy Editor (West), JAMA.

Footnotes
Reprints: Drummond Rennie, MD, JAMA, 515 N State St, Chicago, IL 60610.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?